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Abstract 17 
 18 
Neuropeptide S (NPS) exerts robust anxiolytic and memory enhancing effects, but only in a 19 
non-social context. In order to study whether NPS affects aggressive behavior we used Wistar 20 
rats bred for low (LAB) and high (HAB) levels of innate anxiety-related behaviour, 21 
respectively, which were both described to display increased levels of aggression compared 22 
with Wistar rats not selectively bred for anxiety (NAB). Male LAB, HAB and NAB rats were 23 
tested for aggressive behavior towards a male intruder rat within their home cage (10 min, 24 
resident-intruder [RI] test). Intracerebroventricular (icv) infusion of NPS (1 nmol) 25 
significantly reduced inter-male aggression in LAB rats, and tended to reduce aggression in 26 
HAB and NAB males. However, local infusion of NPS (0.2 or 0.1 nmol NPS) into either the 27 
nucleus accumbens or the lateral hypothalamus did not influence aggressive behavior. Social 28 
investigation in the RI test and general social motivation assessed in the social preference 29 
paradigm were not altered by icv NPS. The anti-aggressive effect of NPS is most likely not 30 
causally linked to its anxiolytic properties, as intraperitoneal administration of the anxiogenic 31 
drug pentylenetetrazole decreased aggression in LAB rats whereas the anxiolytic drug 32 
diazepam did not affect aggression of HAB rats. Thus, although NPS has so far only been 33 
shown to exert effects on non-social behaviors, our results are the first demonstration of anti-34 
aggressive effects of NPS in male rats. 35 
 36 
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Introduction 39 
 40 
Aggressive behavior is an important prerequisite for the acquisition and maintenance of 41 
feeding resources, territory and mating partners and, therefore, for the survival of an 42 
individual and the species. However, dysregulation of aggression among conspecifics can lead 43 
to severe injury and death. Neuropeptides, like arginine vasopressin and oxytocin, have been 44 
shown to be important regulators of inter-male, female and maternal aggression (Ferris, 2005; 45 
Neumann and Landgraf, 2012; Calcagnoli et al., 2013; De Jong et al., 2013), but are also part 46 
of neuronal circuits regulating anxiety in rats and mice (Landgraf et al., 1995; McCarthy et 47 
al., 1996; Bielsky et al., 2005; Blume et al., 2008). With respect to a possible link between 48 
inter-male aggression and anxiety, studies describe either an association between low levels of 49 
anxiety and high levels of aggression (Nyberg et al., 2003; Beiderbeck et al., 2007), or no 50 
such link (de Boer et al., 2003). In rats selectively bred for extremes in innate anxiety, low 51 
anxiety-related behavior (LAB) has been linked to high and abnormal inter-male aggression, 52 
but also male rats with high anxiety-related behavior (HAB) show higher aggression levels 53 
compared with rats not selectively bred for anxiety (NAB) (for review see Neumann et al., 54 
2010). Co-selection of factors regulating aggression along with those regulating both, low and 55 
high, anxiety-related behavior is likely to underlie the behavioral phenotype of LAB and HAB 56 
rats. 57 
The recently discovered neuropeptide S (NPS) exerts strong anxiolytic effects in rats, 58 
including LAB and HAB rats, and mice, when administered into the brain ventricles (icv), via 59 
the nasal route (Xu et al., 2004; Ionescu et al., 2012; Lukas and Neumann, 2012; Slattery et 60 
al., 2012) and locally into the medial amygdala, hypothalamus, or hippocampus (Slattery et 61 
al., 2012; Dine et al., 2013). NPS acts via specific G protein-coupled receptors (NPSR) (Xu et 62 
al., 2004; Reinscheid et al., 2005), which are widely localized within limbic and hypothalamic 63 
brain regions, whereas NPS mRNA expression is restricted to a small population of neurons 64 
between the locus coeruleus and the Barrington nucleus (Xu et al., 2004; Leonard and Ring, 65 
2011). In addition to its anxiolytic properties, NPS facilitates spatial learning and memory in 66 
the Morris water maze (Han et al., 2009), the extinction of aversive memories (Jüngling et al., 67 
2008) as well as object recognition memory (Okamura et al., 2011; Lukas and Neumann, 68 
2012). However, the anxiolytic and memory enhancing effect of NPS were exclusively seen 69 
in a non-social context, as neither social anxiety in the social preference/social avoidance 70 
paradigm nor social memory in the social discrimination test were altered by NPS (Lukas and 71 
Neumann, 2012).  72 
Furthermore, NPS was shown to inhibit reward and addiction behaviors. Thus, NPS inhibits 73 
morphine-induced conditioned place preference in mice (Li et al., 2009) and reduces alcohol 74 
intake in an alcohol-preferring rat breeding line (Badia-Elder et al., 2008). In this context it is 75 
of interest that the high aggression of LAB rats is driven by an increased neuronal activity in 76 
the nucleus accumbens (NAc), part of the reward circuitry (Beiderbeck et al., 2012). High 77 
aggression in LAB rats was also accompanied by an increased neuronal activation in 78 
hypothalamic subregions including the anterior and lateral hypothalamus (LH) (Beiderbeck et 79 
al., 2012) - regions that are also activated after icv NPS administration (Kallupi et al., 2010) 80 
and express high levels of NPSR mRNA (Leonard and Ring, 2011). This makes NPS a 81 
promising candidate for reducing inter-male aggression in highly aggressive individuals.  82 
The primary aim of this study was, therefore, to investigate the effect of NPS on inter-male 83 
aggression in LAB and HAB rats as models of hyper-aggression, with non-selected (NAB) 84 
rats serving as low-aggressive controls. Additionally, we aimed to localize the putative anti-85 
aggressive effects of NPS in promising target regions that are important in the regulation of 86 
both reward and aggression, i.e. the NAc and LH. Finally, to investigate a putative link 87 
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between aggression and anxiety, we monitored inter-male aggressive behavior after treatment 88 
with established anxiolytic or anxiogenic agents.  89 
 90 
Materials and Methods  91 
Animals 92 
Experiments were carried out on male Wistar rats either selectively bred for low (LAB) and 93 
high (HAB) anxiety-related behavior or non-selected rats (NAB) in the animal facilities of the 94 
University of Regensburg (Neumann et al., 2010). Rats were housed in groups of 4 - 6 under 95 
standard laboratory conditions (12:12 h light/dark cycle with lights on at 06:00 h, 21 ± 1 °C, 96 
60 % ± 5 % humidity, standard rat chow and water ad libitum). For behavioral testing, adult 97 
resident LAB, HAB, and NAB male rats (350 – 450 g) were each housed in an observation 98 
cage (40 × 24 × 35 cm) together with a female Wistar rat (Charles River, Sulzfeld, Germany) 99 
for 10 days (12:12 h light/dark cycle with lights off at 12:00) to stimulate territorial behavior 100 
(Flannelly and Lore, 1977; Beiderbeck et al., 2012). Bedding was not changed during the last 101 
3 days prior to the resident-intruder (RI) test. All tests took place during the active phase 102 
starting one hour after lights off, i.e. between 13:00 h and 15:00 h. The experiments were 103 
approved by the Committee on Animal Health and Care of the Government of the Oberpfalz.  104 
Intracerebral implantation of guide cannulas 105 
For intracerebral drug infusion, guide cannulas were stereotaxically implanted either 106 
unilaterally 2 mm above the lateral ventricle or bilaterally 2 mm above the NAc or the LH 107 
[relative to bregma; icv: 1.0 mm posterior, 1.6 mm lateral, 2.0 mm deep; NAc: 1.7 mm 108 
anterior, 1.6 mm lateral, 4.6 mm deep; LH: 1.8 mm posterior, 1.8 mm lateral, 6.0 mm deep; 109 
nose -3.5 mm, (Paxinos and Watson, 1998)]. Rats were anesthetized (Isoflurane, Forene®, 110 
Abbott GmbH & Co. KG, Wiesbaden, Germany), injected with an antibiotic (Baytril®, Bayer 111 
Vital GmbH, Leverkusen, Germany), and mounted on a stereotaxic frame. The guide cannula 112 
(for icv: 21 G, 12 mm; for NAc and LH: 23 G, 12 mm; Injecta GmbH, Germany) was fixed to 113 
the skull with two jeweler’s screws and dental cement (Kallocryl, Speiko-Dr. Speier GmbH, 114 
Muenster, Germany) and closed by a stainless steel stylet (25 G and 27 G, respectively). 115 
Three days prior to and one day after surgery, rats were handled (stroking, holding, cleaning 116 
of stylets) for a total of four days to minimize non-specific stress responses during the 117 
experiment.  118 
 119 
Intracerebral drug application 120 
In order to study the effects of intracerebral NPS infusion, either icv, or locally into the left 121 
and right NAc, or the left and right LH, on aggression and social approach behavior, rats 122 
received either synthetic NPS (icv: 1 nmol/5 µl, i.e. 2 µg/5 µl; NAc/LH: 0.1 or 0.2 nmol/1µl, 123 
i.e. 0.2 or 0.1 µg/1µl; H-6164; Bachem Holding AG, Bubendorf, Switzerland) or vehicle 124 
(sterile Ringer’s solution, pH 7.4, B. Braun Melsungen, Germany) via an infusion cannula 125 
inserted into the guide cannulas and connected to a Hamilton syringe via polyethylene tubing. 126 
After icv or local infusion, the cannula was left in place for 30 s. Infusions were performed 30 127 
min prior to behavioral testing (RI test, elevated pluz-maze [EPM], social preference test). 128 
Doses and time points for icv and local infusions were chosen based on their behavioral 129 
effects in an emotional (EPM) and learning (object recognition) context (Lukas and Neumann, 130 
2012; Slattery et al., 2012). 131 
 132 
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Intraperitonal (ip) injections 133 
The anxiogenic drug pentylenetetrazole (PTZ; 25 mg/kg; Sigma-Aldrich, Steinheim, 134 
Germany) and the anxiolytic drug diazepam (DIA; 2 mg/kg; Ratiopharm, Ulm, Germany) 135 
were injected ip 30 min prior to behavioral testing on the EPM or in the RI test. Based on 136 
Pellow et al. (1985) (20 mg PTZ/kg 5 min before EPM) we tested a dose of 25 mg/kg PTZ 30 137 
min before EPM exposure in a pilot study in order to match the time point of our other 138 
experiments; any convulsive effects,  however, were not found in any of the tested rats. To 139 
minimize unspecific stress responses due to the injection, rats were handled daily during the 140 
early dark phase starting 3 days prior to the experiment by gently placing the rat in a dark tube 141 
(one end closed; length: 17 cm; diameter: 8 cm) and touching their belly. As a result all rats 142 
went into the tube voluntarily without signs of arousal or resistance. 143 
 144 
 145 
Behavioral paradigms 146 
Resident-intruder (RI) test 147 
For behavioral testing of male rats without prior surgery, the female was removed from the 148 
resident’s cage 30 min before the beginning of the RI test. Otherwise, the female rat was 149 
removed from the resident’s cage during surgery, and males were single-housed in their 150 
experimental observation cage thereafter. At the start of the 10-min RI test, an unfamiliar, 151 
non-aggressive, lighter (10 % less body weight) male Wistar rat (Charles River, Sulzfeld, 152 
Germany) was placed into the cage of the resident. 153 
The behavior of the resident was videotaped, and the following behaviors were scored by an 154 
experienced observer blind to breeding line and treatment: aggressive behavior (attack, lateral 155 
threat, offensive upright, keep down, threat, mounting, aggressive grooming), social 156 
investigation (investigating opponent, anogenital sniffing), exploration, self-grooming, 157 
defensive behavior, immobility and other behaviors like food intake or digging (Koolhaas et 158 
al., 1980; Beiderbeck et al., 2012). Behavior was scored in real-time using pre-set computer 159 
keys (Eventlog; Version 1.0, 1986, R. Hendersen).  160 
Social preference test 161 
The effects of icv NPS on social approach/social avoidance behavior was studied using the 162 
social preference paradigm (Lukas et al., 2011). Briefly, rats were placed in a novel arena (40 163 
× 80 × 40 cm, red light), and after 30 sec of habituation, an empty wire-mesh cage (non-social 164 
stimulus; 20 × 9 × 9 cm) was placed at one side wall of the arena for 4 min. The empty cage 165 
was then exchanged by an identical cage containing an unknown adult male Wistar rat (social 166 
stimulus) for 4 min. Exploration times of the non-social and social stimulus (i.e. the time the 167 
rat spent in active olfactory investigation) were scored by an observer blind to the treatment 168 
using JWatcher behavioral observation software (V 1.0, Macquarie University and UCLA). 169 
Data are presented as the percentage of time investigating the non-social versus the social 170 
stimulus, i.e. investigation time/total time [4 min] × 100. A significantly higher percentage of 171 
mean investigation of the social versus the non-social stimulus within one group of rats was 172 
considered social preference. Before each trial, the arena was cleaned with water containing a 173 
low concentration of detergent.  174 
 175 
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Elevated plus-maze (EPM) 176 
The effects of local (NAc, LH) NPS, ip PTZ and ip DIA on non-social anxiety-related 177 
behavior was assessed using the EPM (Pellow et al., 1985), which consisted of two opposing 178 
open (50 × 10 cm, 100 lux) and two opposing closed arms (50 × 10 × 40 cm, 20 lux) 179 
connected by a central area (Beiderbeck et al., 2007). Briefly, the EPM was made of dark gray 180 
plastics, elevated 80 cm above the floor and surrounded by an opaque curtain to avoid 181 
external disturbance. Before each trial, the maze was cleaned with water containing a low 182 
concentration of a detergent. The rat was placed in the central area facing a closed arm. The 183 
percentage of time spent on the open arms during the 5-min test (time on open arms / time on 184 
open and closed arms × 100) was assessed as anxiety-related behavior, and the number of 185 
entries in the closed arms as measurement for locomotion. Behavior was recorded by means 186 
of a video camera mounted above the platform and scored by a trained observer (Plus-maze 187 
version 2.0; E. Fricke).  188 
 189 
Experimental design 190 
 191 
By performing an initial RI test before beginning of all the experiments, we confirmed that 192 
the level of aggression in both the future vehicle and treatment groups did not differ between 193 
the two groups to be compared. 194 
 195 
Experiment 1:  Effects of icv NPS on inter-male aggression and general social motivation 196 
In order to study the effects of icv NPS on territorial aggression, groups of male LAB (n = 197 
20), HAB (n = 20), and NAB (n = 18) residents were infused icv with either NPS (1 nmol/5 198 
µl) or vehicle (VEH) 30 min prior to the RI test. To further test for the specificity of NPS 199 
effects on aggressive behavior, the general social motivation of several of these LAB (n = 19) 200 
and HAB (n = 16) rats was tested in the social preference test 30 min after icv infusion of 201 
either NPS or VEH two days after the RI test has been performed. Rats were infused with the 202 
identical icv treatment received prior to the RI test. 203 
Experiment 2: Effects of infusion of NPS into the NAc and LH of LAB rats 204 
In order to localize the anti-aggressive effects of NPS either NPS (0.1 nmol/1µl, 0.2 205 
nmol/1µl) or VEH were bilaterally infused into the NAc (n = 18) or the LH (n = 46) of 206 
aggressive LAB rats. Both brain regions were chosen based on high local NPSR expression 207 
(Leonard and Ring, 2011) and an increase in neuronal activation in response to the display of 208 
high aggression in LAB rats (Beiderbeck et al., 2012). Three days later, several of these rats 209 
(NAc, n = 18; LH, n = 22) were tested on the EPM for anxiety-related behavior. 210 
Experiment 3: Effects of anxiolytic (DIA) and anxiogenic (PTZ) drugs on inter-male 211 
aggression 212 
In order to study the effects of pharmacological manipulation of anxiety-related behavior on 213 
aggression (Neumann et al., 2010), LAB (n = 23) rats  were injected with the anxiogenic drug 214 
PTZ (25 mg/kg, ip) (Cruz et al., 1994), HAB (n = 24)males with the anxiolytic drug DIA (2 215 
mg/kg, ip) (Pellow et al., 1985) and NAB (n = 23) rats with both PTZ and DIA; respective 216 
controls received VEH (Ringer’s solution, 1ml/kg; ip). Our pilot experiments (data not 217 
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shown) showed that the low anxiety-related behavior of male LAB rats cannot be further 218 
reduced by DIA, thus, they were only injected with PTZ. Similarly, the high anxiety level of 219 
HAB rats cannot be further increased by PTZ; therefore, HABs were only treated with DIA. 220 
Thirty min after the injection, the experimental rats were tested for aggressive behavior in the 221 
RI test. Additional groups of LAB (n = 12) and HAB (n = 16) males were treated with PTZ or 222 
DIA, respectively, and their anxiety-related behavior was tested on the EPM. The anxiolytic 223 
and anxiogenic effects of DIA and PTZ on the EPM, respectively, are already very well 224 
established in non-selected Wistar rats (Pellow et al., 1985; Cruz et al., 1994). 225 
 226 
Histology 227 
To verify the infusion sites, rats were killed by an overdose of anesthetics after the end of the 228 
behavioral tests. Icv brains were infused via the guide cannula with ink (5µl), instantly cut 229 
coronally and checked for staining of the ventricle. Locally infused brains were frozen in pre-230 
chilled n-methylbutane on dry ice, and infusion sites were localized on 40-µm coronal 231 
cryostat sections stained with cresyl violet. 232 
Statistics 233 
All statistical analyses were performed using the software package SPSS (version 19). 234 
Behavioral parameters of the RI test were analyzed using either Students t-test, when two 235 
treatments were compared (e.g. vehicle vs. NPS, or vehicle vs. PTZ) or a one-way analysis of 236 
variance (ANOVA) followed by a post-hoc analysis using Bonferroni correction, if 237 
appropriate, in case three treatments groups were compared (e.g. Vehicle, PTZ, DIA). If 238 
variance equality was violated, adjusted p-values together with unadjusted degrees of freedom 239 
are presented with the t-values. Separate statistical analysis of treatment effects as described 240 
above has been performed on LAB, HAB and NAB rats, as experiments on the 3 rat lines 241 
were performed at different times. However, the parameter overall aggressive behavior has 242 
been compared between all three lines using a two-way ANOVA (factors rat line × treatment). 243 
Social investigation in the social preference test was compared using a 2 × (2) mixed model 244 
ANOVA (drug treatment [between subject] × stimulus [within-subject]) followed by a post-245 
hoc comparison using Bonferroni correction. EPM behavior was analyzed using Student’s t-246 
test. Data are presented as mean + standard error of the mean (SEM). Statistical significance 247 
was set at p < 0.05. 248 
 249 
Results 250 
Experiment 1: Effects of icv NPS on inter-male aggression in LAB, HAB and NAB males 251 
and no effects on social preference in LAB and HAB rats 252 
LAB rats treated with icv NPS (1 nmol) displayed less total aggressive behavior (t(18) = 2.38; p 253 
< 0.05; Fig. 1A) and spent more time immobile (t(18) = -2.62; p < 0.05; Table 1) in the RI test 254 
compared with VEH-treated LABs. No significant differences between NPS- and VEH-255 
treated LAB residents were found in social investigation, exploration or any other behavior 256 
investigated (Fig. 1A). There were no significant treatment effects on distinct aggressive 257 
parameters. 258 
In HAB rats, a trend towards reduced total aggressive behavior (t(18)  = 2.03; p = 0.057; Fig. 259 
1B), and an increase in immobility (t(18) = 2.59; p < 0.05; Table 1) were found after icv NPS-260 
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treatment compared with VEH. No significant differences between NPS- and VEH-treated 261 
rats were found with respect to social investigation and exploration or any other behaviors 262 
investigated (Fig. 1B). 263 
NPS-treated NAB rats spent more time with cage exploration (t(16) = -3.80; p < 0.01 versus 264 
VEH), whereas social investigation, immobility and aggressive behavior did not significantly 265 
differ between the NAB treatment groups (Fig. 1C, Table 1).  266 
However, overall statistics of aggressive behavior on all three strains, reveals a significant 267 
reduction of aggression between NPS- and VEH-treated rats (F(1,52) = 12.1; p < 0.005), 268 
indicating a general anti-aggressive effect of NPS (Fig. 1). Overall statistics did not reveal an 269 
interaction effect (strain × treatment; F(2,52) = 55.4; p = 0.685). 270 
Social preference: In confirmation of previous results found in male NAB rats (Lukas and 271 
Neumann, 2012), icv NPS did not alter social preference behavior in LAB (F(1,17) = 0.003; p = 272 
0.96; Fig. 2A) and HAB (F(1,13) = 0.004; p = 0.95; Fig. 2B) rats as indicated by a similar 273 
percentage of time exploring the social stimulus compared with VEH-treated rats. 274 
Whereas both VEH- (p < 0.01) as well as NPS-treated (p < 0.05) HAB males showed a 275 
preference for the social stimulus compared to the non-social stimulus (Fig. 2A), in contrast, 276 
social preference behavior was missing in LAB males (Fig. 2B). 277 
 278 
Experiment 2: No effects of local infusions of NPS into the NAc and LH on inter-male 279 
aggression and anxiety-related behavior in LAB rats 280 
RI test: Bilateral infusion of NPS into the NAc (Vehicle: 20.94 % ± 5.49; NPS [0.1 281 
nmol]:17.58 % ± 2.33; NPS [0.2 nmol]: 15.10 % ± 4.22) and the LH (Vehicle: 55.05 % ± 282 
6,75; NPS [0.2 nmol]: 59.55 % ± 5,05) did not change total aggressive behavior. 283 
 EPM: Similarly, LAB rats bilaterally infused with NPS (0.2 nmol) either into the NAc or the 284 
LH did not differ from VEH-treated rats in the percentage of time spent on the open arms of 285 
the EPM (Table 1). Although there were no changes on home cage locomotion following NPS 286 
infusion into the LH in the RI test, NPS infusion into the LH significantly decreased the 287 
number of entries in the closed arms (t(20) = -2.64; p < 0.05 versus VEH; Table 1).  288 
 289 
Experiment 3: Effects of ip PTZ and DIA on inter-male aggression and anxiety-related 290 
behavior  291 
RI test: 292 
LAB residents treated with the anxiogenic drug PTZ displayed less inter-male aggression (t(21) 293 
= 5.72; p < 0.001) and social investigation (t(21) = 2,48; p < 0.05), but more exploration (t(21) = 294 
-5.21; p < 0.001; Fig. 3A) and immobility (t(21) = -2.41; p = 0.05; Table 1) compared with 295 
VEH-treated males. 296 
In contrast, HAB males treated with the anxiogenic drug DIA displayed more immobility (t(22)  297 
= -2.37; p < 0.05 versus VEH; Table 1), whereas aggression, social investigation and 298 
exploration remained unchanged after DIA-treatment (Fig. 3B). 299 
In NAB residents treated with either PTZ, DIA or vehicle (Fig. 3C), there was no treatment 300 
effect on total aggression (F(2,20) = 2,02; p = 0.16) or immobility (F(2,20) = 0,90; p = 0.42). In 301 
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contrast, there was a significant treatment effect on social investigation (F(2,20) = 4,35; p < 302 
0.05) and exploration (F(2,20) = 18,3; p < 0.001). In detail, PTZ-treated NAB males spent more 303 
time with exploration (p < 0.001) than VEH- as well as DIA-treated NAB rats (Fig. 3C). 304 
EPM:  The established anxiogenic and anxiolytic effects of PTZ and DIA (Pellow et al., 1985; 305 
Cruz et al., 1994) were confirmed in LAB and HAB rats, respectively. PTZ-treated male LAB 306 
rats spent less time on the open arms of the EPM (t(10) = 4.25; p < 0.01 versus VEH; Table 1) 307 
indicating an increase in anxiety-related behavior, whereas the number of open arm entries 308 
remained unchanged. In contrast, DIA-treated HAB rats showed increased time on the open 309 
arms (t(14) = -2.31; p < 0.05 versus VEH; Table 1) with an unchanged number of open arm 310 
entries.  311 
 312 
Discussion  313 
In the present study, we describe for the first time that central NPS modulates social behavior 314 
in rats, as it reduces inter-male aggression regardless of the innate aggression level. However, 315 
attempts to localize the anti-aggressive effect of NPS in brain regions involved in reward and 316 
aggression, namely the NAc and the LH, failed suggesting that NPS may mediate these 317 
effects in other brain regions or indirectly via modulation of anxiety. In order to investigate 318 
the latter hypothesis, LAB, HAB and NAB rats were treated with either established 319 
anxiogenic drug PTZ and/or the anxiolytics DIA (Pellow et al., 1985; Cruz et al., 1994; 320 
Liebsch et al., 1998). Increasing anxiety in male LAB rats via PTZ resulted in a reduction of 321 
aggressive behavior accompanied by a reduction in social investigation, whereas reducing 322 
anxiety in HAB rats via DIA did not affect aggression. 323 
Former studies have demonstrated potent properties of NPS to reduce anxiety- and fear-324 
related behaviour (Xu et al., 2004; Jüngling et al., 2008; Ionescu et al., 2012; Lukas and 325 
Neumann, 2012; Slattery et al., 2012; Dine et al., 2013), and modulates learning and memory 326 
(Han et al., 2009; Okamura et al., 2011; Lukas and Neumann, 2012) when applied either icv 327 
or locally into the amygdala and ventral hippocampus in rats and mice. In contrast, social 328 
behaviors including social approach, social anxiety and social memory were not altered by 329 
synthetic NPS, and the endogenous NPS system does not seem to contribute to the regulation 330 
of these aspects of social behavior (Lukas and Neumann, 2012). However, our findings 331 
provide the first evidence for the involvement of NPS in the regulation of inter-male 332 
aggression. The strongest anti-aggressive effect of icv NPS was found in LAB rats, which 333 
show the highest level of aggression. In contrast, the aggression-reducing effect of NPS was 334 
less pronounced in HAB and NAB males, probably due to their generally lower level of 335 
aggression in the RI test (Beiderbeck et al., 2012). Additionally, the aggression-reducing 336 
effect of NPS could be based on the reduction of rewarding effects of aggression, which were 337 
only found in LAB rats (Beiderbeck et al., 2012). Further, differences in the endogenous NPS 338 
system between LAB, HAB and NAB rats have been demonstrated. In particular, increased 339 
NPSR expression in LAB compared to HAB males within the hypothalamic paraventricular 340 
nucleus (PVN) of rats and the medial amygdala of mice (Slattery et al., 2012) may begin to 341 
explain the differences observed in the present study.  342 
Importantly, the NPS-induced decrease in aggression is not due to a general reduction in 343 
social motivation, as the time rats spend in non-aggressive social investigation during the RI 344 
test and social approach behavior in the social preference test was not altered by NPS in any 345 
of the groups. These results are in confirmation of our recent findings of NPS exerting 346 
anxiolytic (Slattery et al., 2012) and memory-enhancing (Lukas and Neumann, 2012) effects 347 
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only in a non-social context without altering social preference behavior or social 348 
discrimination abilities. 349 
Former studies have repeatedly shown increased locomotion and arousal after central NPS 350 
treatment, when testing was performed in unknown, stressful environments or in the early 351 
light phase (Xu et al., 2004; Smith et al., 2006; Rizzi et al., 2008). In contrast, we found a 352 
significant increase in immobility after icv NPS in both LAB and HAB rats during the RI test. 353 
This may be a consequence of the reduced time these rats spent with aggressive behavior. In 354 
our experiments, residents were tested in their home cage during the early dark phase, i.e. the 355 
active phase of rats, which may further explain the lack of arousal after NPS-treatment.  356 
In an attempt to identify the brain region(s) responsible for the anti-aggressive effect of NPS 357 
we selected two regions, the NAc and LH, characterized by both the presence of NPSRs 358 
(Leonard and Ring, 2011) and by increased neuronal activity in response to the display of 359 
high aggression in LAB residents (Beiderbeck et al., 2012). In addition to the NAc and the 360 
LH, NPSRs were identified in several brain regions belonging to the reward system and in the 361 
hypothalamic part of the stress axis including the ventral tegmental area and the arcuate 362 
hypothalamic nucleus, as well as in other regions involved in the regulation of aggression like 363 
the anterior and dorsal hypothalamic area (Leonard and Ring, 2011). Furthermore, the NAc 364 
was selected as a target region as we have recently demonstrated that the high aggression 365 
level of LAB rats is mediated via the mesolimbic reward system, i.e. the dopamine system in 366 
the NAc (Beiderbeck et al., 2012). As NPS may directly act on brain regions known to be 367 
important for the regulation of aggression, we also chose the LH for local NPS infusions 368 
(Tulogdi et al., 2010). This was supported by the finding of Kallupi et al. (2010) 369 
demonstrating that icv infusion of NPS triggers neuronal activation in the LH in mice. 370 
Although previously shown to exert local effects on anxiety in other brain regions (Jüngling et 371 
al., 2008; Ionescu et al., 2012; Slattery et al., 2012; Dine et al., 2013) bilateral infusion of 372 
NPS into either the NAc or LH prior to behavioral testing did not alter inter-male aggression 373 
in the RI test or anxiety-related behavior on the EPM. Although it cannot be excluded that 374 
higher doses of NPS may be effective, this suggests that these two regions are not mediating 375 
the anxiolytic and anti-aggressive effects of NPS. Thus, further studies are needed to localize 376 
the aggression-reducing effect of NPS. Potential target regions are the anterior hypothalamus 377 
and the arcuate nucleus, which are not only rich in NPSRs (Leonard and Ring, 2011), but also 378 
implicated in the regulation of aggression (Veening et al., 2005; Siever, 2008; Beiderbeck et 379 
al., 2012). Furthermore, the ventral tegmental area, which is also rich of NPSRs and the 380 
upstream element of the dopaminergic reward system, could be a target for future studies, but 381 
local neuronal activation did not increase during the display of high aggression in LAB rats 382 
(Beiderbeck et al., 2012) Additionally, further studies should investigate, whether infusion of 383 
NPS into regions involved in its anxiolytic effect, like the amygdala or the ventral 384 
hippocampus (Jüngling et al., 2008; Dine et al., 2013) also leads to a reduction of aggression 385 
in male rats. Another option for indirect regulation of aggression is that hypothalamic regions 386 
linked to the regulation of hypothalamus-pituitary-adrenal (HPA) axis activity, for example 387 
the PVN, may be of importance for the anti-aggressive effects of NPS. Alterations in the 388 
reactivity of the HPA axis to social stressors may also underlie behavioral changes in the RI 389 
test. However, both high and low HPA axis reactivity have been associated with high 390 
aggression levels (Haller and Kruk, 2006; Veenema et al., 2007; Neumann et al., 2010), 391 
resulting in the hypothesis of reactive versus non-reactive aggression (Koolhaas et al., 1999). 392 
This opens the route for speculations that NPS reduces aggression via modulating the HPA 393 
axis and thereby the social stress response. However, HPA response after aggressive 394 
encounters is already increased in highly aggressive LAB rats (Veenema et al., 2007), and 395 
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NPS is considered to result in a further activation of the HPA axis; at least under basal 396 
conditions (Smith et al., 2006).  397 
Finally, we investigated whether the effect of NPS on aggression could be due to its robust 398 
anxiolytic properties. Thus, LAB and HAB males were treated with established anxiogenic 399 
(PTZ) and anxiolytic (DIA) substances prior to exposure to the RI test. PTZ-treatment of LAB 400 
rats indeed increased their low basal anxiety level, and reduced their high level of aggressive 401 
behavior in the RI test compared with vehicle-treated LAB males. Moreover, DIA-treatment 402 
of HAB rats resulted in reduced anxiety levels as seen after NPS treatment, but did not alter 403 
inter-male aggression. In NAB rats, neither PTZ nor DIA altered their low level of aggression 404 
in the RI test. In the last years, the potential link between aggression and anxiety has been 405 
discussed controversially (for review see Neumann et al., 2010). Such a link has been shown, 406 
for example, in different strains of mice (Cases et al., 1995; Oliveira-Dos-Santos et al., 2000; 407 
Nyberg et al., 2003), whereas other studies did not find such a link. For example, enkephalin 408 
knockout mice and North Carolina mice show both increased inter-male aggression and 409 
increased anxiety (Nehrenberg et al., 2009). In LAB and HAB rats, both individuals with low 410 
and high innate anxiety levels are more aggressive compared with NAB rats. However, LAB 411 
males display not only the highest level, but also abnormal forms of aggression (Beiderbeck et 412 
al., 2012). Additionally, mice bred for short- or long-attack latency do not differ in anxiety-413 
related behavior (Hogg et al., 2000). Also, oxytocin knockout mice characterized by low 414 
levels of anxiety do not consistently differ in aggression compared with wild-type mice 415 
(Winslow et al., 2000). Thus, it has been suggested that aggression and anxiety can be 416 
independently regulated. In support, highly aggressive North Carolina mice show a reduction 417 
in both aggression and anxiety when treated with DIA (Nehrenberg et al., 2009), whereas the 418 
HAB rats in the present study did not show a decrease in aggression after DIA-treatment. 419 
Also, increasing anxiety-related behavior by PTZ, and infusion of the anxiolytic NPS reduced 420 
aggression in LAB rats. Taken together, there are multiple studies rather suggesting lack of a 421 
direct link between and independent regulation of aggression and anxiety. Therefore, the anti-422 
aggressive properties of NPS are not likely to be caused by its strong anxiolytic effect.  423 
In conclusion, central infusion of NPS is effective to reduce inter-male aggression in rats, an 424 
effect which was not accompanied by a reduction of social interaction or social preference. 425 
Our experiments further suggest that the anti-aggressive effect of NPS is independent of its 426 
anxiolytic action, as alterations in anxiety may or may not result in alterations in aggression. 427 
Thus, our study is the first to identify the regulatory capacity of NPS to modify social 428 
behavior. 429 
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 587 
Figure Legends 588 
 589 
Fig. 1 Behavior of LAB (A), HAB (B), and NAB (C) rats during the RI test. NPS (1nmol) was applied 590 
icv 30 min before testing. Social investigation, cage exploration, and aggressive behavior are 591 
calculated as percentage of total time (10 min). Numbers in parentheses indicate group size. Date are 592 
means + SEM, * p < 0.05 versus vehicle, (*) 0.1 > p > 0.05. Student’s t-test. 593 
 594 
Fig. 2 Behavior of LAB (A) and HAB (B) rats in the social preference test. NPS (1 nmol) was applied 595 
30 min before testing. Social preference was reflected by time the experimental rats spent sniffing the 596 
object and the social stimulus, respectively. NPS (1nmol) was applied icv 30 min before testing. Time 597 
of investigation to the stimulus and time spent in the contact zone are calculated as percentage of total 598 
time (4min). Numbers in parentheses indicate group size. Data are means + SEM, # p <0.05 versus 599 
non-social stimulus; 2 × (2) mixed model ANOVA (drug treatment [between subject] × stimulus 600 
[within-subject]) followed by a post-hoc test (Bonferroni). 601 
 602 
 603 
Fig. 3 Behavior of LAB (A), HAB (B), and NAB (C) rats during the RI test. Pentylenetetrazol (PTZ, 604 
25 mg/kg) and Diazepam (DIA, 2 mg/kg) were applied ip 30 min before testing. Social investigation, 605 
cage exploration, and aggressive behavior are calculated as percentage of total time (10 min). 606 
Numbers in parentheses indicate group size. Date are means + SEM, * p < 0.05 versus vehicle. One-607 
way-ANOVA followed by post-hoc test (Bonferroni) and student’s t-test, respectively. 608 
 609 
 610 
 611 
 612 
 613 
 614 
 615 
 616 
 617 
 618 
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 620 
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 624 
 625 
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Table 1: Anxiety-related behavior of LAB, HAB, and NAB rats on the elevated plus-maze (EPM) 631 
and home cage immobility during the resident- intruder (RI) test. Neuropeptide S (NPS, 0.2 nmol) 632 
was applied intracerebroventricularly (icv) or bilaterally in the nucleus accumbens (NAc) or the 633 
lateral hypothalamus (LH). Pentylenetetrazol (PTZ, 25 mg/kg) and Diazepam (DIA, 2 mg/kg) were 634 
injected ip, 30 min before testing. Date are means ± SEM, * p < 0.05 versus vehicle. Student’s t-635 
test. 636 
 637 
Paradigm     EPM    RI (home cage) 638 
Readout   time open arm (%)  entries closed arm immobility (%) 639 
Treatment   Veh  drug  Veh   drug  Veh           drug 640 
LAB (NPS/icv)   anxiolytic (Slattery et al., 2012)  3.9 ± 0.9        12 ± 3.0 * 641 
HAB (NPS/icv)  anxiolytic (Slattery et al., 2012)  4.9 ± 1.4        28 ± 9.0 * 642 
NAB (NPS/icv)  anxiolytic (Slattery et al., 2012)  4.0 ± 2.0        10 ± 2.7 643 
LAB(NPS/NAc) 69.2 ± 3.3 71.6 ± 5.4 6.5 ± 0.7   5.6 ± 0.8 7.2 ± 2.3        5.5 ± 1.0 644 
LAB(NPS/LH)   60.9 ± 4.9 71.5 ± 4.9 4.6 ± 0.7   4.7 ± 0.8 * 4.6 ± 1.0        6.8 ± 2.3 645 
LAB(PTZ/ip)   76.1 ± 4.2 44.3 ± 6.2 * 6.3 ± 0.9   5.3 ± 0.3 3.5 ± 0.67      9.3 ± 2.3 * 646 
HAB(DIA/ip)     3.2 ± 2.2 16.6 ± 6.0 * 1.7 ± 0.7   2.6 ± 0.6 3.0 ± 0.82      9.2 ± 2.5 *647 
  648 
Figure 1.TIF
Figure 2.TIF
Figure 3.TIF
